Drug intelligence / Profile preview

SpheroGel

Development stage
Unknown
Lead developer
BIOMIR service
Modality
Hydrogel Systems → Drug Delivery Systems
Administration
Intraarticular, Subcutaneous, Topical
01

Overview

SpheroGel is an injectable, heterogeneous collagen-based hydrogel designed for regenerative medicine, primarily in orthopedics and traumatology. It is composed of animal-derived collagen microparticles and a complex of extracellular matrix components, including glycosaminoglycans and amino acids. The product acts as a biomimetic scaffold and stabilizer for hyaluronic acid, facilitating the restoration of joint tissues, tendons, and muscles. It is characterized by its ability to undergo slow resorption (lasting at least 3 months), providing sustained therapeutic effects in treating osteoarthritis and degenerative joint diseases. In addition to its orthopedic applications, SpheroGel is utilized in aesthetic medicine for skin rejuvenation and moisturization. The product is available in different formulations (Light, Medium, and Long) that vary in cross-linking density and duration of effect.

Brand names
SpheroGel
Other names
SpherogelСферогель

Beyond the preview

Go deeper on SpheroGel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SpheroGel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call